Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03504956 · ClinicalTrials.gov registry record · NA
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
A NA study of Coronary Atherosclerosis, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03504956: Recruiting NA study of Coronary Atherosclerosis, sponsored by Cedars-Sinai Medical Center.
NCT03504956 is a NA study of Coronary Atherosclerosis that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 150 participants, below the 329-participant average among 5 other Coronary Atherosclerosis trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03504956, a NA study of Coronary Atherosclerosis, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conventional imaging methods.
Primary Outcome
PMR is defined as the ratio between the maximal signal intensity from a vessel wall region and the average signal from an adjacent myocardial area. Such metric is used to classify hyper-intense plaques, also known as "hot spots", which has PMR over 1.0.
Conditions Studied
Interventions
- DEVICE Cardiac MRI
- DRUG Contrast
- DRUG Beta blocker
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT03504956 shows while recruiting
NCT03504956 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 329-participant average among 5 other Coronary Atherosclerosis trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Coronary Atherosclerosis appearing as the primary indexed condition, and to 3 interventions - of which Cardiac MRI is the first listed.
NCT03504956 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03504956 about?
NCT03504956 is a clinical study titled "Coronary Atherosclerosis T1-Weighted Characterization (CATCH)". This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conve...
What is the current status of trial NCT03504956?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-07-30. Estimated completion is 2026-12-31.
What conditions does trial NCT03504956 study?
This clinical trial studies the following conditions: Coronary Atherosclerosis.
What interventions are being tested in trial NCT03504956?
The interventions under investigation include: Cardiac MRI (DEVICE), Contrast (DRUG), Beta blocker (DRUG).
Who is sponsoring clinical trial NCT03504956?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03504956 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Using CTA Measures to Define Cardiac Risk In NFL Alumni
RECRUITING
-
Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)
COMPLETED · Phase 3
-
Subclinical Atherosclerosis in HIV-infected Patients
COMPLETED
-
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI